Statins: Separating Myth from Medicine
If your doctor recently recommended a statin, you may be wondering what it is and why it matters. You may also have heard conflicting information or myths about statins — so what’s actually true?… read more
Do GLP-1 Medications Increase the Risk of Cancer?
Glucagon-like peptide-1 receptor agonists or GLP-1 medications, such as semaglutide (Ozempic®, Wegovy®), liraglutide (Victoza®, Saxenda®), and dulaglutide (Trulicity®), are medicines that help manage type 2 diabetes and obesity. They support weight loss and…read more
Rethinking Mirtazapine: Evidence and Best Practices for Managing Unintentional Weight Loss in Older Adults
Mirtazapine is often prescribed to older adults with depression and unintentional weight loss because of its appetite-stimulating properties, particularly in complex cases involving cancer, acquired immunodeficiency syndrome (AIDS), congestive heart failure, or advanced chronic obstructive pulmonary disease (COPD). However, recent evidence and…read more
ARISTOTLE Trial Safety Summary: Apixaban vs. Warfarin in Atrial Fibrillation Brochure
The ARISTOTLE trial was a double-blind, randomized, non-inferiority study comparing apixaban with warfarin for stroke…read more
Continuing Education Monograph SGLT2 Inhibitors in Type 2 Diabetes: Current Role in Glycemic Management and Cardiorenal Risk Reduction
SGLT2 inhibitors were initially developed to improve glycemic control in adults with T2DM, but their role has expanded because of evidence showing…read more
Pembrolizumab Plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma (KEYNOTE-426)
Treatment of advanced clear-cell renal cell carcinoma (RCC) has evolved from monotherapy with vascular endothelial growth factor (VEGF)-targeted agents such as sunitinib to combination therapy that includes immune checkpoint inhibitors, with the goal of improving tumor control. KEYNOTE-426 evaluated whether…read more